Fecal Incontinence clinical trials

Explore recruiting fecal incontinence clinical trials.

Recruiting fecal incontinence studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Fecal Incontinence trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Mechanisms of action on rectal motility of intrarectal botulinum toxin injections in patients with fecal incontinence - MECA-TOX

France

Therapeutic confirmatory (Phase III) EU CTIS Study details

Multicentre, randomised, double-blind, Phase IIb study to evaluate the safety and efficacy of intralesional administration of two doses of expanded adipose tissue allogeneic adult mesenchymal stem cells (AdMSCs ), conditioned in hyaluronic acid hydrogel, as a treatment for patients with faecal incontinence.

Spain

Therapeutic exploratory (Phase II) EU CTIS Study details

Treatment of Chronic Anal Fissure with Ultrasound-Guided Inter-Sphincteric Injections of Botulinum Toxin A

Spain

Therapeutic use (Phase IV) EU CTIS Study details

European, multicentre, single arm (phase I) trial of autologous skeletal muscle derived cell (ASMDC) microcarrier combination for the treatment of faecal incontinence (FI) in women with obstetric anal sphincter injury.

France, Spain, Austria, Denmark

Human Pharmacology (Phase I)- First administration to humans EU CTIS Study details

Repairing Peri-Anal Fistulas with regenerative cell therapeutics (REP-PAF)

Denmark

Phase I and Phase II (Integrated)- First administration to humans EU CTIS Study details

A Phase 3, Multicenter, Randomized, Double-blind, Parallel-group, Safety and Efficacy Study of Linaclotide versus Placebo in Pediatric Subjects, Ages 2 to 5 Years, with Functional Constipation (FC) with a 24-week Open-label Treatment Extension

Netherlands, Bulgaria

Therapeutic confirmatory (Phase III) EU CTIS Study details

Fecal Incontinence trials by city

Fecal Incontinence in Toronto Fecal Incontinence in Vancouver Fecal Incontinence in Montreal Fecal Incontinence in Calgary Fecal Incontinence in Edmonton Fecal Incontinence in Ottawa Fecal Incontinence in Winnipeg Fecal Incontinence in Quebec City Fecal Incontinence in Hamilton Fecal Incontinence in Kitchener Fecal Incontinence in London Fecal Incontinence in Halifax Fecal Incontinence in New York Fecal Incontinence in Los Angeles Fecal Incontinence in Chicago Fecal Incontinence in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease